- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Type 2 diabetes mellitus
- Meeting Date: May 2025
- Public Summary Document (PSD) May 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) May 2025 PBAC Meeting - (Word)
Pioglitazone – May 2025
Pioglitazone: Tablet 15 mg (as hydrochloride), Tablet 30 mg (as hydrochloride), Tablet 45 mg (as hydrochloride); Actos®
Last updated
9 May 2025